Public Company News

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

* Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. * Finished building will be one of the world's largest modular biologics Drug Product (DP) facilities, and will enhance W...

2025-07-29 16:00 4968

Macau's Oriental Pearl district property market poised for growth, fuelled by LRT East Line

The only private housing area directly adjacent to an LRT station, offering seamless connectivity acrossHong Kong, Zhuhai and Macau HONG KONG, July 29, 2025 /PRNewswire/ -- With phased construction of the East Line ofMacau's Light Rapid Transit (LRT) system commencing this month and full operati...

2025-07-29 15:44 4307

Ericsson announces completion of Aduna transaction

* Aduna now a 50:50 joint venture: 50 percent owned by Ericsson and 50 percent owned by twelve communications service providers (CSPs) * Aduna has been operational since its formation announcement on September 11, 2024 * Aduna ecosystem comprises CSP, major developer platform companies, glob...

2025-07-29 15:36 2564

Tigermed Completes Acquisition of Japanese CRO Micron

HANGZHOU, China and TOKYO, July 29, 2025 /PRNewswire/ -- Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Mic...

2025-07-29 13:37 5819

WAIC 2025: Shanghai Electric Debuts First Industrial Humanoid Robot "SUYUAN," Advancing Next-Gen Intelligent Manufacturing through Holistic Value Chain Layout

Boasting full-spectrum industrial capabilities from core technology development to integrated solutions,China's leading innovator drives the next-generation industrial revolution through a comprehensive industry chain strategy SHANGHAI, July 29, 2025 /PRNewswire/ -- Shanghai Electric

2025-07-29 13:14 5437

Introducing DXC Assure Risk Management: AI-Powered Claims Solution for Self-Insured Organizations

ASHBURN, Va., July 29, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced DXC Assure Risk Management, a next-generation solution that unites AI and human expertise to help self-insured organizations better manage employee ca...

2025-07-29 12:01 4174

Forrester To Recognize AIA Group As Its 2025 Customer-Obsessed Enterprise Award Winner At CX Summit APAC

SINGAPORE, July 29, 2025 /PRNewswire/ -- Forrester (Nasdaq: FORR) today announced AIA Group as the winner of its 2025 Customer-Obsessed Enterprise Award

2025-07-29 12:00 4090

Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ

SUZHOU, China, July 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of gastric cancer and ga...

2025-07-29 10:37 3029

Agoda Reveals First-Half 2025 Travel Insights: China, Malaysia, and South Korea Remain Top Visitors to Thailand

BANGKOK, July 29, 2025 /PRNewswire/ -- Digital travel platform Agoda reveals fresh insights into the Thai travel landscape for the first half of 2025. Based on booking data,China, Malaysia, and South Korea are once again the leading markets visitingThailand, followed by Japan and Singapore.

2025-07-29 10:05 3805

Agilent and Nanyang Technological University's NEWRI Sign Agreement to Enhance Water Contaminant Research in Singapore

SINGAPORE, July 29, 2025 /PRNewswire/ -- Agilent Technologies Inc.  (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with theNanyang Environment & Water Research Institute (NEWRI) , outlining their collaboration ...

2025-07-29 09:00 3439

CoAsia SEMI and Rebellions Join Forces to Jointly Develop Next-Generation AI Chiplet Based on REBEL

* Collaboration on Development and Supply of Next-Generation AI Chiplet and Server Software * Development and Verification by 2026; Large-Scale Mass Production Expected SEOUL, South Korea, July 29, 2025 /PRNewswire/ -- CoAsia SEMI (CEO DS, Shin), a system semiconductor design specialist sub...

2025-07-29 08:00 2856

CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series

Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All TOKYO, July 29, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") (OTC: TSPH), a leader in applied artificial intelligence technology, today announced the launch of the Studio Version of Animon....

2025-07-29 08:00 3921

SM nurtures next generation of entrepreneurs

PASAY CITY, Philippines, July 29, 2025 /PRNewswire/ -- Anchored on an inclusive supply chain network, the SM group's partner-MSMEs (micro, small, medium enterprises) have grown alongside the group. Home to the largest MSME community, SM is supporting over 100,000 MSMEs to date. Within the hund...

2025-07-29 06:09 3017

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced the appointment ofGreg Hughes to its Board of Directors effective July 25, 2025. A seasoned enterprise software executive, Hughes brin...

2025-07-29 04:53 3237

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + U.S. & EU reach trade...

2025-07-28 20:55 3585

Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug

- This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks the third approved indication of the drug inChina. - XPOVIO® as a monotherapy in patients with relap...

2025-07-28 18:49 3608

OneConnect International CTO at Fortune Brainstorm AI: Future of Finance Demands Hybrid AI Approach for Trust and Control

SINGAPORE, July 28, 2025 /PRNewswire/ -- The future of artificial intelligence in finance lies in a hybrid approach that combines the generative power of large models with the precision of traditional AI to ensure trust and control, said Dr.Ming Jin, International CTO of OneConnect Financial Tech...

2025-07-28 18:41 4384

SuperX Announces Plan for the Establishment of its AI Supply Center in Japan to Accelerate End-to-End Solution Delivery

The new hub will serve as a regional center for the integration and delivery of SuperX's core AI Server and HVDC products, with a projected annual capacity of 10,000 high-performance AI servers to meet accelerating demand inJapan. SINGAPORE, July 28, 2025 /PRNewswire/ -- Super X AI Technology Lim...

2025-07-28 18:30 5448

China Literature to Report First Half 2025 Financial Results on August 12, 2025

- Earnings Conference Call to be Held on Tuesday, August 12, 2025 at 8:00 pm (Hong Kong Time) / 8:00 am (U.S. Eastern Time) HONG KONG, July 28, 2025 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", 0772.HK), a leading online literature and intellectual property ("IP...

2025-07-28 17:39 6847

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for canc...

2025-07-28 10:40 2714
1 ... 248249250251252253254 ... 904